The persistent challenge of keeping participants engaged in clinical trials has long been treated as a problem that begins only after a patient has consented, but this narrow viewpoint overlooks the vast majority of individuals who disengage before ever setting foot in a clinic. For years, the
Today, we sit down with biopharma expert Ivan Kairatov to explore the high-stakes world of clinical trial supply chains. With deep experience in the industry's technological and research frontiers, Ivan offers a unique perspective on the critical partnerships between sponsors, Contract Research
In the critical moments of treating a suspected opioid overdose, where every second counts, a new study reveals that a common vital sign could be the key to uncovering a hidden and far more complex danger. A groundbreaking investigation suggests that an unusually slow pulse might be the first clear
Today, we have the privilege of speaking with Ivan Kairatov, a biopharma expert at the forefront of technological innovation in research and development. His work delves into one of the most exciting intersections in modern medicine: the use of artificial intelligence to accelerate the fight
The promise of affordable elective surgery in an exotic location has captivated a growing number of patients, but a closer examination reveals a far more complex and costly reality hidden behind the glossy brochures and enticing online advertisements. This burgeoning global industry, built on the
The relentless global rise of hypertension has long been shadowed by its close companion, obesity, creating a public health crisis that has puzzled scientists and clinicians for decades. For years, the prevailing wisdom held that the sheer volume of body fat was the primary driver of high blood
